The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.

Keywords

Biology, Neurodegeneration, Reactive oxygen species, Parkinson's disease, PINK1

References

• Molecular Pathways of Neurodegeneration in Parkinson's DiseaseTed M. Dawson, Valina L. Dawson — 2003
• Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics.Yeni García Pérez, Guillermo Alomá Sarría — 2010
• Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.Sónia C. Correia, Renato X. Santos, George Perry — 2012
• Lipoic Acid and N-acetyl Cysteine Decrease Mitochondrial-Related Oxidative Stress in Alzheimer Disease Patient FibroblastsPaula I. Moreira, Peggy L.R. Harris, Xiongwei Zhu — 2007
• Levodopa and the progression of Parkinson's disease.The Parkinson Study Group — 2004
• Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligaseHideki Shimura, Nobutaka Hattori, Shinichiro Kubo — 2000
• Treatment strategies for Parkinson’s diseaseHong Yuan, Zhenwen Zhang, Li-Wu Liang — 2010
• Neurodegenerative pathways in Parkinson's disease: therapeutic strategies.Sandra M. Cardoso, Paula I. Moreira, Paula Agostinho — 2005
• Modulation of poly(ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells.Mickie Bhatia, James B. Kirkland, Kelly A. Meckling‐Gill — 1995
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonismTohru Kitada, Shuichi Asakawa, Nobutaka Hattori — 1998
• Mechanism of Toxicity in Rotenone Models of Parkinson's DiseaseTodd Sherer, Ranjita Betarbet, Claudia Testa — 2003
• Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes.Natale R. Musso, Sabrina Brenci, Maurizio Setti — 1996
• Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early‐onset Parkinson diseaseS Y Kim, Moon‐Woo Seong, Beomseok Jeon — 2012
• DJ-1 regulation of mitochondrial function and autophagy through oxidative stressMelissa K. McCoy, Mark Cookson — 2011
• Prevalence of Parkinson's disease in the elderlyM. C. de Rijk, Monique M.B. Breteler, G.A. Graveland — 1995
• Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease.Brunella Caronti, Gianluigi Tanda, Carlo Colosimo — 1999
• Formation, Prevention, and Repair of DNA Damage by Iron/Hydrogen Peroxide*Ernst S. Henle, Stuart Linn — 1997
• Reactive oxygen species: from health to disease.Katharine Brieger, Stefania Schiavone, Francis J. Miller — 2012
• Glutathione: an overview of biosynthesis and modulation.Mary E. Anderson — 1998
• Astrocytes and Brain InjuryYongmei Chen, Raymond A. Swanson — 2003

Cited by

• Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized MedicineA.M. Zakharov, E.M. Savitskii — 2014
• Discover the network mechanisms underlying the connections between aging and age-related diseasesBernhard Heuvel — 2016
• Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.Xiaorong Pan, Chunxia Chen, Jianping Huang — 2015
• Peganum Harmala L. Extract Reduces Oxidative Stress and Improves Symptoms in 6-Hydroxydopamine-Induced Parkinson’s Disease in RatsMaryam Rezaei, Sima Nasri, M Roughani — 2016
• Oxidative Modulation of K+ Channels in the Central Nervous System in Neurodegenerative Diseases and AgingChris Peers, John P. Boyle — 2015
• Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cellsBegüm Alural, Ayşegül Özerdem, Jens Allmer — 2015
• Resveratrol relieves ischemia-induced oxidative stress in the hippocampus by activating SIRT1.Zhuangzhi Meng, Jianguo Li, Honglin Zhao — 2015
• Metabolite and Peptide Levels in Plasma and CSF Differentiating Healthy Controls from Patients with Newly Diagnosed Parkinson's DiseaseMiles Trupp, Pär Jonsson, Annika Öhrfelt — 2014
• β‐elemene reverses the drug resistance of A549/DDP lung cancer cells by activating intracellular redox system, decreasing mitochondrial membrane potential and P‐glycoprotein expression, and inducing apoptosisChengcai Yao, Jie Jiang, Yuanrong Tu — 2014
• Oxidative stress and Parkinson’s diseaseJavier Blesa, Inés Trigo‐Damas, Ana Quiroga‐Varela — 2015
• The roles of redox enzymes in Parkinson’s disease: Focus on glutaredoxinWilliam M. Johnson, Amy L. Wilson‐Delfosse, Shu G. Chen — 2015
• Age-dependent action of reactive oxygen species on transmitter release in mammalian neuromuscular junctions.Anastasia Shakirzyanova, Guzel Valeeva, А. R. Giniatullin — 2016
• Biological and physiological role of reactive oxygen species – the good, the bad and the uglyLi Zuo, Tingyang Zhou, Benjamin K. Pannell — 2015
• Estrogen receptor variant ER-α36 is involved in estrogen neuroprotection against oxidative toxicity.Shuai Han, Bin Zhao, Xiaohua Pan — 2015
• Protective effects of isolecanoric acid on neurodegenerative in vitro models.Nuria de Pedro, Juan Cantizani, Francisco Javier Ortiz‐López — 2016
• In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide NanoparticlesUjwal Patil, Shiva Adireddy, Ashvin R. Jaiswal — 2015
• Pterostilbene mediates neuroprotection against oxidative toxicity via oestrogen receptor α signalling pathwaysZhen Song, Shuai Han, Xiaohua Pan — 2015
• Spreading of pathology in neurodegenerative diseases: a focus on human studiesJohannes Brettschneider, Kelly Del Tredici, Virginia M.‐Y. Lee — 2015
• The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex diseaseMartin Horan, D.N. Cooper — 2014
• Alimentation, pesticides et pathologies neurologiquesLudmila Juricek, Xavier Coumoul — 2014

Related papers

• Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson’s disease and beyondJae Ryul Bae, Byoung Dae Lee — 2015
• Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson’s DiseaseGenta Ito, Naoko Utsunomiya‐Tate — 2023
• LRRK2 recruitment, activity, and function in organellesLuis Bonet‐Ponce, Mark Cookson — 2021
• Proteomics analysis of autophagy cargos reveals distinct adaptations in PINK1 and LRRK2 models of Parkinson diseaseJuliet Goldsmith, Alban Ordureau, C. Alexander Boecker — 2023
• Dysregulated LRRK2 Signaling in Response to Endoplasmic Reticulum Stress Leads to Dopaminergic Neuron Degeneration in C. elegansYiyuan Yuan, Pengxiu Cao, Mark A. Smith — 2011
• LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodiesNicolas Dzamko, Amanda M. Gysbers, Rina Bandopadhyay — 2017
• Comprehensive assessment of PINK1 variants in Parkinson’s diseaseLynne Krohn, Francis P. Grenn, Mary B. Makarious — 2020
• Protective effects of superoxide dismutation activity in genetic models of Parkinson’s diseaseAlice Biosa, Roberta Filograna, Vinay K. Godena — 2016